EL.En. (ELN) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
26 Dec, 2025Transaction overview
Finalized sale of 59% (59.18%) of Penta Laser Zhejiang to YOFC for CNY 240 million (approx. EUR 30.5 million), valuing the company at CNY 405 million (approx. EUR 51.5 million), based on 2024 draft results.
Ot-las retains a 19% (19.2%) stake, with a lock-up until 2027; YOFC will manage Penta Laser Zhejiang.
The deal excludes Cutlite Penta and its Brazilian subsidiary due to customer and governance concerns, especially in the US, about foreign control.
Sale proceeds will strengthen the group’s net financial position and primarily repay financing from El.En. to Ot-las.
The agreement is subject to Italian Golden Power approval, regulatory approval, and includes customary co-sale, right of first refusal, and price adjustment clauses.
Deal structure and indemnities
A 5% price reduction applies if Penta Laser Zhejiang misses certain financial targets in 2025 or 2027.
Seller liability capped at 10% of received price for most due diligence findings, except for two cases with unlimited indemnity: the Baoyuan legal dispute and potential impairment of the KBF subsidiary.
Ot-las can sell its remaining stake to YOFC in 2027 at 1.05x net asset value.
Some US customers canceled orders in Q4 2024 due to concerns over Chinese control, but orders resumed after confirming Italian ownership.
The divested activities will be excluded from El.En.'s consolidation perimeter after closing, expected within 90 days.
Financial impact and use of proceeds
PLZ generated €81.8 million revenue and -€7.1 million EBIT in 2024, with a positive net financial position of €9.8 million.
The sale is expected to generate a consolidated gross capital gain of about €6 million, subject to final adjustments.
Sale proceeds will primarily repay financing from El.En. to Ot-las, strengthening the group’s net financial position.
Latest events from EL.En.
- Revenue up 4.4% to €591M, net profit down 15.9%, strong cash, cautious 2026 outlook.ELN
Q4 202516 Mar 2026 - Revenue up 5.1% to €285.3M, EBIT and net income down, Chinese unit sold, outlook positive.ELN
Q2 20253 Feb 2026 - Q1 2025 revenue up 8.8%, EBIT up 12%, with strong growth and positive 2025 outlook.ELN
Q1 202522 Jan 2026 - Net income up 7% to €51.6M as medical growth offset industrial decline; 2025 outlook cautious.ELN
Q4 202422 Jan 2026 - Q3 2024 delivered higher profits and margins, driven by medical growth and a major divestment.ELN
Q3 202422 Jan 2026 - Net income rose 5.9% to €27.3M as EBIT is forecast to exceed 2023 despite lower revenue.ELN
H1 202422 Jan 2026 - Majority of the laser cutting division to be sold to YOFC for EUR 55.3M, boosting cash and focus.ELN
Investor Update15 Jan 2026 - Revenue up 3.9% to €422M, medical leads, financial position strong, 2025 growth confirmed.ELN
Q3 202521 Nov 2025